All Work

Chris Lange

Salesforce Sinks Despite Beating Earnings

Salesforce.com, Inc. (NYSE: CRM) reported its fiscal second-quarter financial results after the markets closed on Tuesday. The company said that it had $0.33 in earnings per share (EPS) and $2.56 billion in revenue, compared…

Chris Lange · 9 years ago

What to Expect From Lowe’s Earnings

Lowe’s is scheduled to release most recent quarterly earnings report before the markets open on Wednesday, after rival Home Depot beat expectations when it reported last week.

Chris Lange · 9 years ago

Why Momo Is Tanking Despite Explosive Growth

Chinese social network Momo reported better-than-expected fiscal second-quarter financial results before the markets opened on Tuesday, but shares tanked.

Chris Lange · 9 years ago

How Kohl’s Is Revamping Its Format

Management believes that the company is continuing to make progress on its initiatives to optimize and rightsize select Kohl’s stores across the country.

Chris Lange · 9 years ago

DSW Wins Big in Q2

Retailer DSW reported better-than-expected fiscal second-quarter financial results before the markets opened on Tuesday.

Chris Lange · 9 years ago

Krystal Biotech Files for IPO

Gene therapy company Krystal Biotech has filed with the SEC regarding its initial public offering.

Chris Lange · 9 years ago

Monday’s Biggest Winners and Losers in the S&P 500

Monday was a relatively flat day for the broad markets on very low volume, as the result of a once-in-a-lifetime solar eclipse that took place across the U.S. The eclipse lasted about 2 hours…

Chris Lange · 9 years ago

Coherus Bio Jumps on Private Placement

Coherus Biosciences, Inc. (NASDAQ: CHRS) watched its shares jump on Monday after the company announced that it plans to raise up to $150 million in a two tranche private placement. A Singapore investment firm,…

Chris Lange · 9 years ago

Ironwood Pharma Muted Despite FDA Approval

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) shares remained relatively muted on Monday after the firm announced a key U.S. Food and Drug Administration (FDA) approval for its gout treatment duzallo. The firm expects duzallo to…

Chris Lange · 9 years ago

Will Herbalife Go Private?

Herbalife Ltd. (NYSE: HLF) has been under fire for years with many investors betting against the firm calling it a scam or a pyramid scheme. Notably among those betting against it is Bill Ackman…

Chris Lange · 9 years ago

Chicago Fed Slips in July

The Chicago Fed National Activity Index (CFNAI) was recently released for the month of July. Consensus estimates were calling for a reading of +0.22 in the expected range of -0.13 to +0.25, but the…

Chris Lange · 9 years ago

Syros Pharma Wins Orphan Designation From FDA

Syros Pharmaceuticals, Inc. (NASDAQ: SYRS) saw its shares make a handy gain early on Monday after the firm announced a critical update that it received from the U.S. Food and Drug Administration. Specifically, the…

Chris Lange · 9 years ago

Why This Is the Best Quarter Applied Materials Has Ever Had

Applied Materials, Inc. (NASDAQ: AMAT) reported its fiscal third-quarter financial results after the markets closed on Thursday. The general consensus after seeing these results is that Applied Materials had its best quarter in the…

Chris Lange · 9 years ago